| __timestamp | Corcept Therapeutics Incorporated | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 24518692 |
| Thursday, January 1, 2015 | 36949000 | 19886580 |
| Friday, January 1, 2016 | 45240000 | 12631689 |
| Sunday, January 1, 2017 | 62416000 | 21977998 |
| Monday, January 1, 2018 | 81289000 | 20759000 |
| Tuesday, January 1, 2019 | 100359000 | 20838000 |
| Wednesday, January 1, 2020 | 105326000 | 121812000 |
| Friday, January 1, 2021 | 122356000 | 152137000 |
| Saturday, January 1, 2022 | 152848000 | 83231000 |
| Sunday, January 1, 2023 | 184259000 | 122706000 |
Unleashing insights
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Corcept Therapeutics Incorporated and TG Therapeutics, Inc. have been navigating this challenge since 2014. Over the years, Corcept has shown a steady increase in SG&A expenses, peaking at approximately $184 million in 2023, a 428% rise from 2014. Meanwhile, TG Therapeutics experienced a more volatile trajectory, with a significant spike in 2021, reaching around $152 million, before dropping to $123 million in 2023. This fluctuation highlights TG Therapeutics' aggressive investment in administrative functions, possibly reflecting strategic shifts or expansion efforts. In contrast, Corcept's consistent growth in expenses suggests a more stable, perhaps conservative, approach. Understanding these trends offers valuable insights into each company's operational strategies and financial priorities, providing a window into their long-term sustainability and market positioning.
Operational Costs Compared: SG&A Analysis of AstraZeneca PLC and Corcept Therapeutics Incorporated
Zoetis Inc. vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs TG Therapeutics, Inc.
Breaking Down SG&A Expenses: Grifols, S.A. vs TG Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Corcept Therapeutics Incorporated or Catalyst Pharmaceuticals, Inc.
Corcept Therapeutics Incorporated or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Corcept Therapeutics Incorporated vs Amicus Therapeutics, Inc.
Selling, General, and Administrative Costs: Corcept Therapeutics Incorporated vs PTC Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and PTC Therapeutics, Inc.
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Vericel Corporation Trends and Insights
Breaking Down SG&A Expenses: TG Therapeutics, Inc. vs Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: TG Therapeutics, Inc. vs ImmunityBio, Inc. Trends and Insights